Cartesian Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+744K	72.8%	$15.59	+$11.6M
Sells	6	-278K	27.2%	$17.34	-$4.82M
Net	-5	+466K	45.6%		+$6.77M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Elizabeth Hoge	10%+ Owner	$121M			Oct 11, 2024
Timothy A. Springer	Director, 10%+ Owner	$104M	+$11.6M	+12.6%	Apr 9, 2025
Murat Kalayoglu	Director, 10%+ Owner	$16.7M			Jan 2, 2025
Carsten Brunn	President and CEO, Director	$3.44M	-$290K	-7.78%	Jan 3, 2025
Peter G. Traber	Chief Medical Officer	$1.64M			Sep 25, 2023
Blaine Davis	Chief Financial Officer	$1.6M	-$134K	-7.75%	Jan 3, 2025
Metin Kurtoglu	Chief Technology Officer	$1.11M	-$2.51M	-69.4%	Jan 3, 2025
Lloyd P. Johnston	Chief Operations Officer	$922K			Jan 4, 2023
Takashi Kei Kishimoto	Chief Scientific Officer	$839K			May 30, 2023
Michael Singer	Director	$639K			Jan 2, 2025
Milos Miljkovic	Chief Medical Officer	$620K	-$939K	-60.2%	Jan 3, 2025
Aymeric Sallin	Director	$547K			Jan 2, 2024
Kevin Tan	Chief Financial Officer	$427K			Jan 3, 2022
Christopher Jewell	Chief Scientific Officer	$255K	-$918K	-78.3%	Jan 10, 2025
Emily English	Chief Operations Officer	$221K	-$30.1K	-12%	May 12, 2025
Timothy C. Barabe	Director	$86.6K			Jan 2, 2025
Ando Goran	Director	$59.3K			Jan 2, 2023
Cox Carrie Smith	Director	$57.9K			Jan 2, 2025
Zenner Patrick J	Director	$40.4K			Jan 2, 2025
Nishan DeSilva	Director	$35.1K			Jan 2, 2025
Kemal Malik	Director	$34.3K			Jan 2, 2025
Ann K. Donohue	VP Finance	$8.63K			May 27, 2021
Scott Myers	Director				Nov 13, 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.